Determination of absolute concentrations of cardiac high-energy phosphatesusing P-31-MR-spectroscopy and SLOOP in healthy and diseased myocardium.

Citation
M. Beer et al., Determination of absolute concentrations of cardiac high-energy phosphatesusing P-31-MR-spectroscopy and SLOOP in healthy and diseased myocardium., ROFO-F RONT, 171(1), 1999, pp. 65-68
Citations number
11
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN
ISSN journal
09366652 → ACNP
Volume
171
Issue
1
Year of publication
1999
Pages
65 - 68
Database
ISI
SICI code
0936-6652(199907)171:1<65:DOACOC>2.0.ZU;2-R
Abstract
Purpose: A quantitative P-31-MR-spectroscopic technique was used to assess the energy metabolism in healthy and diseased myocardium. Methods: P-31-spe ctra were acquired on a 1.5 T scanner using a 3D-chemical shift imaging tec hnique. Based on the anatomical information provided by H-1-images, SLOOP ( Spatial Localization with Optimal Pointspread Function) allows to obtain sp ectra from defined compartments. With SLOOP a free voxel shape with adaptio n to anatomic structures, e.g. the myocardium, is possible. Absolute values for phosphocreatine (PCr) and adenosine triphosphate (ATP) were determined using an external standard. Results: P-31-spectra showed only minimal cont amination by surrounding tissue. The standard deviation for the determined values of healthy volunteers was low. Compared to healthy volunteers, reduc ed PCr and ATP concentrations were seen for dilative cardiomyopathies and c oronary artery disease and unchanged concentrations were observed for hyper tensive heart disease. Conclusion: P-31-MR-spectroscopy with SLOOP allows a non-invasive, quantitative analysis of cardiac energy metabolism.